Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | Dr. Mark J. LittonPresident, CEO & Director | 17,10k | 0,00 | Derivative Exercise and Retained Stock | - | 59,89k | 39,95% |
| 2026-03-03 | Dr. Mark J. LittonPresident, CEO & Director | -5,16k | 27,69k | Derivative Exercise and Sale | 5,37 | 59,89k | - |
| 2026-03-03 | Mr. Robert RenningerCFO | 2,99k | 0,00 | Derivative Exercise and Retained Stock | - | 15,85k | 23,29% |
| 2026-03-03 | Mr. Robert RenningerCFO | -906,00 | 4,87k | Derivative Exercise and Sale | 5,37 | 15,85k | - |
| 2026-03-03 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 4,40k | 0,00 | Derivative Exercise and Retained Stock | - | 18,38k | 31,46% |
| 2026-03-03 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -1,33k | 7,13k | Derivative Exercise and Sale | 5,37 | 18,38k | - |
| 2026-03-03 | Dr. Kevin ChurchChief Scientific Officer | 4,50k | 0,00 | Derivative Exercise and Retained Stock | - | 25,18k | 21,74% |
| 2026-03-03 | Dr. Kevin ChurchChief Scientific Officer | -1,36k | 7,30k | Derivative Exercise and Sale | 5,37 | 25,18k | - |
| 2026-03-03 | Dr. Javier San MartinChief Medical Officer | 5,70k | 0,00 | Derivative Exercise and Retained Stock | - | 15,89k | 55,92% |
| 2026-03-03 | Dr. Javier San MartinChief Medical Officer | -1,72k | 9,24k | Derivative Exercise and Sale | 5,37 | 15,89k | - |
| 2025-12-31 | Dr. Javier San MartinChief Medical Officer | 3,02k | 0,00 | Derivative Exercise and Retained Stock | - | 10,19k | 42,19% |
| 2025-12-31 | Dr. Javier San MartinChief Medical Officer | -1,64k | 11,31k | Derivative Exercise and Sale | 6,88 | 10,19k | - |
| 2025-12-31 | Dr. Mark J. LittonPresident, CEO & Director | 8,25k | 0,00 | Derivative Exercise and Retained Stock | - | 42,80k | 23,87% |
| 2025-12-31 | Dr. Mark J. LittonPresident, CEO & Director | -2,59k | 17,79k | Derivative Exercise and Sale | 6,88 | 42,80k | - |
| 2025-12-31 | Mr. Robert RenningerCFO | 939,00 | 0,00 | Derivative Exercise and Retained Stock | - | 12,86k | 7,88% |
| 2025-12-31 | Mr. Robert RenningerCFO | -297,00 | 2,04k | Derivative Exercise and Sale | 6,88 | 12,86k | - |
| 2025-12-31 | Dr. Kevin ChurchChief Scientific Officer | 2,79k | 0,00 | Derivative Exercise and Retained Stock | - | 20,68k | 15,60% |
| 2025-12-31 | Dr. Kevin ChurchChief Scientific Officer | -876,00 | 6,03k | Derivative Exercise and Sale | 6,88 | 20,68k | - |
| 2025-12-31 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 2,79k | 0,00 | Derivative Exercise and Retained Stock | - | 13,98k | 24,95% |
| 2025-12-31 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -876,00 | 6,03k | Derivative Exercise and Sale | 6,88 | 13,98k | - |
| 2025-12-18 | Perceptive Advisors LLCSocietà | 1,32M | 8,38M | Acquisto | 6,35 | 1,86M | 244,13% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
